Astra Zeneca Sustainability Profile
AstraZeneca PLC, a leading global biopharmaceutical company, is headquartered in Cambridge, GB. Founded in 1999 through the merger of Astra AB and Zeneca Group PLC, the company has established a strong presence in key operational regions, including North America, Europe, and Asia. Specialising in the research, development, and manufacturing of innovative medicines, AstraZeneca focuses on areas such as oncology, cardiovascular, renal, and respiratory diseases. With a commitment to advancing healthcare, AstraZeneca is renowned for its unique portfolio of products, including groundbreaking therapies like Tagrisso and Imfinzi. The company has achieved significant milestones, including rapid vaccine development during the COVID-19 pandemic, solidifying its position as a market leader in the pharmaceutical industry. AstraZeneca continues to drive innovation, aiming to improve patient outcomes worldwide.
DitchCarbon Score
How does Astra Zeneca's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Astra Zeneca's score of 97 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Astra Zeneca's reported carbon emissions
In 2024, AstraZeneca reported significant carbon emissions, totalling approximately 6,000,000,000 kg CO2e across all scopes. This includes 125,386,000 kg CO2e from Scope 1, 14,210,000 kg CO2e from market-based Scope 2 emissions, and a staggering 5,897,822,000 kg CO2e from Scope 3 emissions. The previous year, 2023, saw similar figures with total emissions of about 5,917,160,000 kg CO2e, comprising 180,898,000 kg CO2e from Scope 1, 19,940,000 kg CO2e from market-based Scope 2, and 5,917,160,000 kg CO2e from Scope 3. AstraZeneca has set ambitious climate commitments, aiming for a 98% absolute reduction in Scope 1 and 2 GHG emissions by 2026, using 2015 as a baseline. Additionally, the company targets a 50% reduction in Scope 3 emissions by 2030 from a 2019 baseline, with specific goals to cut emissions from fuel and energy-related activities, upstream leased assets, and downstream leased assets by 80% by 2030. Furthermore, AstraZeneca aims for a 95% reduction in emissions from the use of sold products by 2030. The company is also committed to achieving net-zero greenhouse gas emissions across its value chain by 2045, with a long-term goal of reducing Scope 3 emissions by 90% by the same year. These targets align with the Science Based Targets initiative (SBTi) and reflect AstraZeneca's commitment to sustainability and climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2006 | 2007 | 2008 | 2015 | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Astra Zeneca's Industry?
How Carbon Intensive is Astra Zeneca's Location?
Astra Zeneca's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Astra Zeneca has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Frequently Asked Questions
Common questions about Astra Zeneca's sustainability data and climate commitments